Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Cancer Genomics & Proteomics|April 28, 2017
Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast CancersSofia Levva, Vassiliki Kotoula, Ioannis Kostopoulos, et al.
Cancer Medicine|September 22, 2018
Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapyMarinos Tsiatas, Konstantine T Kalogeras, Kyriaki Manousou, et al.
BMC Cancer|July 3, 2026
Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY studySofia Agelaki, Stamatia Demiri, Athanasios Kotsakis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2008
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) studyGerasimos Aravantinos, George Fountzilas, Aristotelis Bamias, et al.
Clinical Colorectal Cancer|August 13, 2019
Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and BevacizumabGeorge Pentheroudakis, Leonidas Mavroeidis, Kyriaki Papadopoulou, et al.
Breast Cancer Research and Treatment|March 22, 2012
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group StudyFlorentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou, et al.
BMC Cancer|July 4, 2012
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysisDimitrios Pectasides, George Papaxoinis, Konstantine T Kalogeras, et al.
BMC Cancer|February 5, 2013
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypesGeorge Pentheroudakis, Vassiliki Kotoula, Wendy De Roock, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 2025
Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final outcome, immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group studyHelena Linardou, Kyriaki Papadopoulou, Nikolaos Korfiatis, et al.
Anticancer Research|May 7, 2017
Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast CancerTitika-Marina Strati, Vassiliki Kotoula, Ioannis Kostopoulos, et al.
Pageof 11